These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 22220

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Preliminary clinical studies of a new benzodiazepine derivative].
    De Marino V, Stella L.
    Rass Int Clin Ter; 1968 Oct 31; 48(20):1284-7. PubMed ID: 5746268
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical physiognomy of chlorprothixene and clopentixol.
    Rimestad S.
    Acta Psychiatr Belg; 1974 Sep 31; 74(5):491-9. PubMed ID: 4471029
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of the therapeutic effect of lower and higher doses of diazepam with a placebo during short-term administration in neuroses].
    Bojanovský J, Hánysová Z, Bouchal M, Martinec P.
    Act Nerv Super (Praha); 1967 Nov 31; 9(4):370. PubMed ID: 4889066
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of a new benzodiazepine preparation, S-804, for the treatment of psychoneurotic and psychosomatic disorders by double-blind cross-over test].
    Tanaka H, Takayama I, Ookubo N, Yoshimuta S, Kono Y.
    Saishin Igaku; 1970 May 31; 25(5):1128-36. PubMed ID: 4912179
    [No Abstract] [Full Text] [Related]

  • 10. Major or minor tranquilizers for relief of common symptoms of psychoneurosis?
    Krivda JF.
    J Psychiatr Nurs Ment Health Serv; 1974 May 31; 12(4):28-33. PubMed ID: 4368887
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Indications for clothiapine in neurotic patients].
    Gallart Capdevila JM.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975 May 31; 3(2):93-102. PubMed ID: 238366
    [No Abstract] [Full Text] [Related]

  • 13. [Experiences with diazepan and diazetard in neuropsychiatry].
    Garbin O, Vartanian V.
    Hospital (Rio J); 1969 Jul 31; 76(1):161-74. PubMed ID: 5307521
    [No Abstract] [Full Text] [Related]

  • 14. [Significance of narrow frequency bands of the EEG spectrum for demonstrating the effect of diazepam in patients with borderline mental disorders].
    Bochkarev VK, Serebriakova TV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991 Jul 31; 91(10):73-7. PubMed ID: 1665660
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the therapeutic spectrum of entumine-chloro-2-11-dibenzothiazepine. A study based on 50 clinical cases].
    Haker O, Nassi G, Cohn D.
    Encephale; 1972 Jul 31; 61(6):550-9. PubMed ID: 4664637
    [No Abstract] [Full Text] [Related]

  • 16. [Contribution to the treatment of the "nervous school child" in general practice].
    Schneider K.
    Hippokrates; 1967 Oct 31; 38(20):820. PubMed ID: 5600578
    [No Abstract] [Full Text] [Related]

  • 17. [Medazepam. A new tranquilizer: simple test, intraindividual comparisons and combination therapy].
    Spiegelberg U, Petrilowitsch N, Betz B.
    Arzneimittelforschung; 1968 Dec 31; 18(12):1559-63. PubMed ID: 5756249
    [No Abstract] [Full Text] [Related]

  • 18. [Dipiperon treatment in a psychiatric out-patient clinic for children and youths].
    Müller-Küppers M.
    Acta Paedopsychiatr; 1971 Dec 31; 38(2):40-6. PubMed ID: 4942603
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of neuroses in children using vitamin-D2].
    Amidshin SS.
    Wien Z Nervenheilkd Grenzgeb; 1973 Dec 31; 31(3):234-40. PubMed ID: 4273128
    [No Abstract] [Full Text] [Related]

  • 20. [Experience with the ataraxic Masmoran in pediatrics].
    Jäkle G.
    Med Klin; 1967 Aug 11; 62(32):1244. PubMed ID: 5593003
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.